2021
Cognitive decline following acute viral infections: literature review and projections for post-COVID-19
Damiano R, Guedes B, de Rocca C, de Pádua Serafim A, Castro L, Munhoz C, Nitrini R, Filho G, Miguel E, Lucchetti G, Forlenza O. Cognitive decline following acute viral infections: literature review and projections for post-COVID-19. European Archives Of Psychiatry And Clinical Neuroscience 2021, 272: 139-154. PMID: 34173049, PMCID: PMC8231753, DOI: 10.1007/s00406-021-01286-4.Peer-Reviewed Original ResearchConceptsAcute viral infectionViral infectionCognitive declineHuman cognitionCoronavirus disease 2019Possible cognitive declineAsymptomatic individualsBrain dysfunctionDisease 2019Human dementiaNeuropsychiatric issuesCognitive sequelaeAlzheimer's diseaseNarrative reviewInfectionInfectious diseasesHealth leadersDiseaseCOVID-19COVID-19 pandemicIndirect pathwaysCognitionCurrent knowledgeRecent findingsLiterature review
2019
Genetic risk for Alzheimer's disease and functional brain connectivity in children and adolescents
Axelrud L, Sato J, Santoro M, Talarico F, Pine D, Rohde L, Zugman A, Junior E, Bressan R, Grassi-Oliveira R, Pan P, Hoffmann M, Simioni A, Guinjoan S, Hakonarson H, Brietzke E, Gadelha A, Pellegrino da Silva R, Hoexter M, Miguel E, Belangero S, Salum G. Genetic risk for Alzheimer's disease and functional brain connectivity in children and adolescents. Neurobiology Of Aging 2019, 82: 10-17. PMID: 31376729, PMCID: PMC7658444, DOI: 10.1016/j.neurobiolaging.2019.06.011.Peer-Reviewed Original ResearchConceptsAlzheimer's diseaseAD-PRSBrain connectivityGenetic riskRight superior temporal gyrusFunctional brain connectivityMagnetic resonance imagingInhibitory controlSuperior temporal gyrusTau pathologyAD developmentPolygenic risk scoresRisk scoreRight precuneusResonance imagingTau proteinTemporal gyrusDiseaseBrain connectionsEarly lifePathology networkFunctional networksRiskPorto AlegreMemory performance
2014
Searching for the Immune Basis of Obsessive-Compulsive Disorder
Teixeira AL, Rodrigues DH, Marques AH, Miguel EC, Fontenelle LF. Searching for the Immune Basis of Obsessive-Compulsive Disorder. NeuroImmunoModulation 2014, 21: 152-158. PMID: 24557049, DOI: 10.1159/000356554.Peer-Reviewed Original ResearchConceptsObsessive-compulsive disorderImmune parametersAnti-basal ganglia antibodiesParticular immune profileRheumatic feverImmune profileComorbid conditionsImmune basisAutoimmune diseasesImmune cellsPsychotropic drugsClinical observationsObsessive-compulsive symptomsPatientsUnequivocal changesOCD patientsElevated frequencyDisordersFeverEtiopathogenesisCytokinesSymptomsDiseaseAntibodies
2006
Tourette syndrome: treatment
Hounie A, Rosário-Campos M, Quarantini L, Sampaio A, Alvarenga P, Diniz J, Lopes A, Seixas A, Pinto A, Chacon P, Prado H, Belotto C, Motta M, De Mathis M, De Mathis M, Borcatto S, Carvalho M, Miguel E. Tourette syndrome: treatment. 2006, 156-205. DOI: 10.1201/b14454-9.Peer-Reviewed Original ResearchTourette syndromeGilles deSimilar medical historyMultiple motor ticsGilles de la TouretteCase seriesMedical historyMotor ticsParticular physicianPatientsSymptomsTouretteDiseaseTreatmentEventual appearanceStrange diseaseDifferent treatmentsLa TouretteChoreaSyndromeCase historiesPsychologicPhysiciansHistorySu.75. Association of Polymorphisms Within the Promoter Region of the Tumor Necrosis Factor-Alpha Gene with Clinical Outcomes of Rheumatic Heart Disease
Ramasawmy R, Fae K, Spina G, Victora G, Tanaka A, Palacios S, Hounie A, Miguel E, Oshiro S, Goldberg A, Kalil J, Guilherme L. Su.75. Association of Polymorphisms Within the Promoter Region of the Tumor Necrosis Factor-Alpha Gene with Clinical Outcomes of Rheumatic Heart Disease. Clinical Immunology 2006, 119: s185. DOI: 10.1016/j.clim.2006.04.502.Peer-Reviewed Original Research
2003
Obsessive-Compulsive Symptoms, Obsessive-Compulsive Disorder, and Related Disorders in Parkinson's Disease
Maia A, Pinto A, Barbosa E, Menezes P, Miguel E. Obsessive-Compulsive Symptoms, Obsessive-Compulsive Disorder, and Related Disorders in Parkinson's Disease. Journal Of Neuropsychiatry 2003, 15: 371-374. PMID: 12928516, DOI: 10.1176/jnp.15.3.371.Peer-Reviewed Original ResearchMeSH KeywordsAgedCase-Control StudiesComorbidityDiagnosis, DifferentialFemaleFunctional LateralityHumansMaleMiddle AgedObsessive-Compulsive DisorderParkinson DiseasePersonality InventoryPsychiatric Status Rating ScalesReproducibility of ResultsSomatoform DisordersStereotyped BehaviorTic DisordersTourette SyndromeTrichotillomania
1999
Relationship between obsessive-compulsive disorders and diseases affecting primarily the basal ganglia
Maia A, Barbosa E, Menezes P, Filho E. Relationship between obsessive-compulsive disorders and diseases affecting primarily the basal ganglia. Clinics 1999, 54: 213-221. PMID: 10881070, DOI: 10.1590/s0041-87811999000600008.Peer-Reviewed Original Research
1990
Neuropsychiatric disorders in systemic lupus erythematosus: a multidisciplinary review.
Miguel Filho E, Pereira R, de Almeida O, Hirsch R, Lafer B, Fang T, Busatto Filho G, de Arruda P. Neuropsychiatric disorders in systemic lupus erythematosus: a multidisciplinary review. Sao Paulo Medical Journal 1990, 108: 174-82. PMID: 2095621.Peer-Reviewed Original ResearchConceptsSystemic lupus erythematosusLupus erythematosusClinical featuresNeuropsychiatric alterationsPsychiatric changesChronic diseasesDifferential diagnosisPsychic symptomsNeuropsychiatric disordersPatientsDiseaseDiagnosisMultidisciplinary reviewCorticosteroidsErythematosusHypertensionUremiaPathogenesisSymptomsInfection
1989
Catatonic syndrome caused by autoimmune disease: spontaneous remission.
Lichtenstein A, Calish I, Oliveira R, Miguel Filho E, Rocha A. Catatonic syndrome caused by autoimmune disease: spontaneous remission. Clinics 1989, 44: 312-5. PMID: 2486424.Peer-Reviewed Original ResearchConceptsCSF immune complexesAutoimmune diseasesImmune complexesCatatonic syndromeCerebrospinal fluidPositive antinuclear factorSystemic lupus erythematosusAntinuclear factorLupus erythematosusRare manifestationSystemic involvementSystemic manifestationsSpontaneous remissionImmunosuppressive drugsPsychiatric manifestationsCatatonic patientsImmunologic testsCase reportMetabolic disturbancesPsychiatric effectsNucleolar patternSchizophrenic disordersValuable markerDiseasePsychiatric picture